Need for Kidney Transplantation in HIV-positive Individuals: Results of a Survey in Italy

References

• Chapuis AG, Paolo Rizzardi G, D’Agostino C, Attinger A, Knabenhans C, Fleury S, et al. Effects of mycophenolic acid on human immunodeficiency virus infection in vitro and in vivo. Nat Med 2000; 6: 762–8.
   Google Scholar
• Coull JJ, Turner D, Melby T, Betts MR, Lanier R, Margolis DM. A pilot study of the use of mycophenolate mofetil as a component of therapy for multidrug-resistant HIV-1 infection. J Acquir Immune Defic Syndr 2001; 26: 423–34.
   PubMed Web of Science ®Google Scholar
• Bouscarat F, Samuel D, Simon F, Debat P, Bismuth H, Saimot AG. An observational study of 11 French liver transplant recipients infected with human immunodeficiency virus type 1. Clin Infect Dis 1994; 19: 854–9.
   PubMed Web of Science ®Google Scholar
• Schwarz A, Offermann G, Keller F, Benhold I, L’age-Stehr J, Krause PH, Mihatsch MJ. The effect of cyclosporin on the progression of human immunodeficiency virus type 1 infection transmitted by transplantation: data on 4 cases and review of the literature. Transplantation 1993; 55: 95–103.
   Google Scholar
• Bing EG, Hays RD, Jacobson LP, Chen B, Gange SJ, Kass NE, et al. Health-related quality of life among people with HIV disease: results from the Multicenter AIDS Cohort Study. Qual Life Res 2000; 9: 55–63.
   PubMed Web of Science ®Google Scholar
• Lee LM, Karon JM, Selik R, Neal JJ, Fleming PL. Survival after AIDS diagnosis in adolescents and adults during the treatment era, United States, 1984–1997. JAMA 2001; 285: 1308–15.
   Google Scholar
• Hogg RS, Yip B, Chan KJ, Wood E, Craib KJ, O’Shaughnessy MV, Montaner JS. Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy. JAMA 2001; 286: 2568–77.
   Google Scholar
• Klotman PE. HIV-associated nephropathy. Kidney International 1999; 56: 1161–76.
   PubMed Web of Science ®Google Scholar
• Barbiano di Belgiojoso G, Trezzi M, Scorza D, Barone MT, Landriani N, Genderini A, Bertoli S. HIV infection in dialysis centres in Italy: a nationwide multicentre study. J Nephrol 1998; 11: 249–54.
   PubMedGoogle Scholar
• Ahuja TS, Brien WAO. Special issues in the management of patients with ESRD and HIV infection. Am J Kidney Dis 2003; 41: 279–91.
   PubMed Web of Science ®Google Scholar
• Ahuja TS, Borucki M, Grady J. HAART improves survival of HIV-infected haemodialysis patients. Am J Kidney Dis 2000; 36: 574–80.
   Google Scholar
• Ortiz C, Meneses R, Jaffe D, Fernandez JA, Perez G, Bourgoignie JJ. Outcome of patients with human immunodeficiency virus on maintenance haemodialysis. Kidney Intern 1988; 34: 248–53.
   PubMed Web of Science ®Google Scholar
• Prachalias AA, Pozniak A, Taylor C, Srinivasan P, Muiesan P, Wendon J, et al. Liver transplantation in adults coinfected with HIV Transplantation 2001; 72: 1684–8.
   Google Scholar
• Schliefer K, Paar WD, Aydemir G, Wolff M, Rockstroth JK, Spengler U, Sauerbruch T. Orthotopic liver transplantation in a 33-y-old patient with fulminant hepatitis B and HIV infection. Dtsch Med Wochenschr 2000; 125: 523–6.
   Google Scholar
• Kuo PC, Stock PG. Transplantation in the HIV patient. Am J Transplant 2001; 1: 13–7.
   PubMed Web of Science ®Google Scholar
• Steinman T, Becker BN, Frost AE, Olthoff KM, Smart FW, Suki WN, Wilkinson AH. Clinical Practice Committee, American Society of Transplantation. Guidelines for the referral and management of patients eligible for solid organ transplantation Transplantation 2001; 71: 1189–204.
   Google Scholar
• Hochegger K, Mayer GJ, Rosenkranz AR. Is HIV infection a contraindication for kidney transplantation? Nephrol Dial Transplant 2003; 18: 217–8.
   PubMedGoogle Scholar
• Gow PJ, Pillay D, Mutimer D. Solid organ transplantation in patients with HIV infection. Transplantation 2001; 72: 177–81.
   Google Scholar
• Spital A. Should all human immunodeficiency virus-infected patients with end-stage renal disease be excluded from transplantation? Transplantation 1998; 65: 1187–91.
   PubMed Web of Science ®Google Scholar
• Dorfman T, Weimann A, Borsetti A, Walsh CT, Gottlinger HG. Active-site residues of cyclophilin A are crucial for its incorporation into human immunodeficiency virus type 1 virions. J Virol 1997; 71: 7110–3.
   Google Scholar
• Thali M. Cyclosporins: immunosuppressive drugs with anti-HIV-1 activity. Mol Med Today 1995; 1: 287–91.
   PubMedGoogle Scholar
• Thomson AW, Bonham CA. Inhibition of T-lymphocyte activation and apoptotic cell death by cyclosporin A and tacrolimus (FK506): its relevance to therapy of HIV infection. Adv Exp Med Biol 1995; 374: 211–6.
   PubMedGoogle Scholar
• Sheikh AM, Wolf DC, Lebovics E, Goldberg R, Horowitz HW Concomitant human immunodeficiency virus protease inhibitor therapy markedly reduces tacrolimus metabolism and increases blood levels. Transplantation 1999; 68: 307–9.
   PubMed Web of Science ®Google Scholar
• Anonymous. Italian Registry of Dialysis and Transplantation: Report 2000. http://www.sin-ridt.org/sin-ridt/sin-ridt.org.htm
   Google Scholar
• Costigliola P, Tumietto F, Zagnoli A, Chiodo F. Need for liver transplant of HIV + subjects. First results of a specific survey in Italy. Project HOST. AIDS 2003 Sep 26; 17: 2119–21.
   Google Scholar
• Roland ME, Stock PG. Review of solid-organ transplantation in HIV-infected patients. Transplantation 2003; 75: 425–9.
   PubMed Web of Science ®Google Scholar
• Stock PG, Roland ME, Carlson L, Freise CE, Roberts JP, Hirose R, et al. Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study. Transplantation 2003; 76: 350–5.
   Google Scholar
• Dave MB, Shabih K, Blum S. Maintenance haemodialysis in patients with HIV-associated nephropathy. Clinical Nephrology 1998; 50: 367–74.
   Google Scholar
• Tumietto F, Costigliola P, Chiodo F and for HOST Group. The need for transplantation of HIV subjects in Italy: preliminary results of HOST project. Transplantation Proceedings 2003; 35: 1003–4.
   Google Scholar